ARPC5 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.90243393155743E-13 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.15899999597602E-08 |
Normal-vs-Stage2 |
2.803800E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.381200E-03 |
Stage1-vs-Stage2 |
5.790400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.901250E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.652400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.39279715433349E-11 |
Normal-vs-AfricanAmerican |
2.262800E-01 |
Normal-vs-Asian |
2.150000E-02 |
Caucasian-vs-AfricanAmerican |
8.485000E-01 |
Caucasian-vs-Asian |
5.552000E-01 |
AfricanAmerican-vs-Asian |
7.140800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.58200000006148E-07 |
Normal-vs-Female |
1.39710000013338E-07 |
Male-vs-Female |
3.142400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.277600E-03 |
Normal-vs-Extreme_Weight |
3.59299999974638E-07 |
Normal-vs-Obese |
1.563550E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.342440E-01 |
Normal_Weight-vs-Obese |
2.936800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.383000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.988200E-01 |
Normal-vs-Age(41-60Yrs) |
6.56270000010117E-07 |
Normal-vs-Age(61-80Yrs) |
2.69730000002077E-07 |
Normal-vs-Age(81-100Yrs) |
2.155200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.430400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.429600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.739000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.305200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.315000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.644200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.755400E-01 |
Normal-vs-Grade 3 |
6.184000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.553000E-01 |
Grade 2-vs-Grade 4 |
7.755400E-01 |
Grade 3-vs-Grade 4 |
6.184000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.77690126238417E-11 |
Normal-vs-N1 |
9.035300E-03 |
N0-vs-N1 |
8.625700E-02 |
|
|